ATP Is Saving the Lives of Cancer Patients and Reducing Their
Pain
- A desktop-size,
first-of-its-kind, bioreactor grows stem cells (Aastrom
Biosciences) and:
- Produces clinically useful quantities of cells from
small amounts of bone marrow and umbilical cord blood
- Is useful for a broad range of cellular therapies (e.g.,
leukemia, lymphoma, and lung, breast, and colon cancer)
- Is less invasive, less painful, and less costly.
ATP is making future detection of breast cancer more affordable
for routine use
- ATP enabled
a next generation, all-digital mammography system (GE
Medical Systems) that will:
- Reach increased market penetration faster
- Produce fast and acurate mammograms at lower cost
- Make routine use more affordable
- Lead to improved medical outcomes, including saving
lives.
ATP Is Paving the
Way for Organ Transplantation (livers, kidneys, and other
organs)
- Genetic engineering and animal cloning techniques (Revivicor,
formerly PPL
Therapeutics) are:
- Accelerating organ transplantation using animal tissue
that the body won't reject
- Meeting acute need for livers, hearts, and other organs.
ATP Is Accelerating New Drug Discovery
- New automated
processes for analyzing how genes and proteins function
(Curagen).
- Fully-automated
DNA-sequencing technology (GeneTrace).
- New mathematical
software is speeding up drug discovery (Molecular
Simulations).
ATP Is Improving Orthopedic Care
- A new
bioabsorbable polymer (Integra
LifeSciences) derived from tyrosine for
medical implants:
- Does not adversely affect tissue or bone, or emit toxic
substances when it degrades
- Is dissolvable and absorbable by the body
- Eliminates the need for a second surgical removal
- Is useful for orthopedic, weight-bearing devices such
as large surgical screws for repairing cartilage damage
by attaching soft tissue to bone in the knee or shoulder
- May help in preventing some types of degenerative arthritic
diseases.
Factsheet 1.B2 (September 2001) |
